CO-MasterLogo@4x_300 DPI.png
Cullinan Oncology Announces Updated Phase 1/2a Data for CLN-081 in NSCLC EGFR Exon 20 Patients
December 16, 2021 06:30 ET | Cullinan Oncology, Inc.
CLN-081 continues to demonstrate a differentiated clinical profile at the recommended Phase 2 dose of 100mg BID Continued high response rate with favorable safety and tolerability profile observed in...
CO-MasterLogo@4x_300 DPI.png
Cullinan Oncology to Provide Clinical Update for CLN-081 in NSCLC EGFR Exon 20 Patients
December 13, 2021 07:00 ET | Cullinan Oncology, Inc.
CAMBRIDGE, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology therapies,...
gmi 2018.png
World Millets Market value to surpass $12 billion by 2025: Global Market Insights, Inc.
June 10, 2019 06:00 ET | Global Market Insights, Inc
Selbyville, Delaware, June 10, 2019 (GLOBE NEWSWIRE) -- The Millets market is highly fragmented and has been witnessing participation from various producers and processors. FPOs and organic...
iambic Announces Availability of Health & Diet Manager for BlackBerry
March 26, 2009 13:05 ET | iambic, Inc.
SAN JOSE, CA--(Marketwire - March 26, 2009) - iambic, Inc., a leading provider of innovative productivity-enhancing software, today announced the availability of Health & Diet Manager for...